Alnylam Pharmaceuticals Market Sentiment

Alnylam Pharmaceuticals Inc

ALNYNASDAQ

Trade with Public

$226.79

-0.87-0.38%

마지막 업데이트: Oct 27, 4:47 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

실적: Q3 2026 실적이 내일 목 10월 29th에 개장 전 발표됩니다.

컨퍼런스 콜: 내일 8:30 오전에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

Alnylam Pharmaceuticals Market Sentiment - Benzinga

Alnylam Pharmaceuticals Market Sentiment

Market sentiment signals for Alnylam Pharmaceuticals (ALNY): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 7.7% short float

Options Flow▼ 1.27 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

1.27

More puts — Bearish

370 calls · 471 puts

Avg Consensus PT

$418

+84.0%

Highest Price Target

$583

+156.9%

Citigroup

Lowest Price Target

$253

+11.5%

Wells Fargo

Short Interest

7.7%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 15, 2026	UBS	Joon Lee—	+56.0%	$550 → $354	Assumes	Buy
Oct 14, 2026	Citigroup	Eric Joseph—	+41.0%	$340 → $320	Maintained	Buy
Oct 14, 2026	Wells Fargo	Derek Archila—	+11.5%	$256 → $253	Maintained	Equal-Weight
Oct 8, 2026	RBC Capital	Luca Issi—	+52.0%	$350 → $345	Maintained	Outperform
Sep 30, 2026	JP Morgan	Jessica Fye—	+62.6%	$375 → $369	Maintained	Overweight
Sep 21, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+100.5%	$455 → $455	Maintained	Buy
Sep 8, 2026	Jefferies	Faisal Khurshid—	+14.6%	$230 → $260	Maintained	Hold
Sep 2, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+100.5%	$455 → $455	Maintained	Buy
Aug 19, 2026	BMO Capital	David Lebowitz—	+40.1%	$318	Initiate	Outperform
Aug 14, 2026	Wells Fargo	Derek Archila—	+12.8%	$316 → $256	Maintained	Equal-Weight
Aug 4, 2026	Truist Securities	Danielle Brill—	+38.8%	$410 → $315	Maintained	Buy
Aug 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+100.5%	$485 → $455	Maintained	Buy
Aug 3, 2026	Raymond James	Martin Auster—	+85.1%	$420 → $420	Upgrade	Outperform→Strong Buy
Aug 3, 2026	Citigroup	Eric Joseph—	+49.8%	$380 → $340	Maintained	Buy
Aug 3, 2026	Barclays	Eliana Merle—	+98.3%	$527 → $450	Maintained	Overweight
Jul 31, 2026	JP Morgan	Jessica Fye—	+65.2%	$400 → $375	Maintained	Overweight
Jul 31, 2026	RBC Capital	Luca Issi—	+54.2%	$445 → $350	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Michael Ulz—	+32.2%	$400 → $300	Maintained	Equal-Weight
Jul 31, 2026	Oppenheimer	Kostas Biliouris—	+54.2%	$500 → $350	Maintained	Outperform
Jul 31, 2026	Wells Fargo	Derek Archila—	+39.2%	$377 → $316	Maintained	Equal-Weight
Jul 31, 2026	Stifel	Paul Matteis—	+40.1%	$444 → $318	Maintained	Buy
Jul 31, 2026	Chardan Capital	Keay Nakae—	+87.3%	$425 → $425	Maintained	Buy
Jul 30, 2026	Needham	Joseph Stringer—	+57.3%	$510 → $357	Maintained	Buy
Jul 22, 2026	JP Morgan	Jessica Fye—	+76.2%	$420 → $400	Maintained	Overweight
Jul 14, 2026	B of A Securities	Tazeen Ahmad—	+80.6%	$460 → $410	Maintained	Buy